Neuro-Biotech Pursues the Implementation of its Licensees Network and Signs a LOI with Israel

BASEL, Switzerland, Jan. 25 /CNW Telbec/ - Neuro-Biotech Corp. (MRES-OTSQB) is pleased to announce the signing of a Letter of Intent with a major distributor in Israel. Both groups are discussing the details of a Licensing Agreement based on similar terms and conditions as the recently negotiated agreement with the Russian company Credo-TM.

Furthermore, Neuro-Biotech intends to contract the manufacturing of the tests ordered by its Licensee in Israel and to that effect discussions have already taken place with Sigma-Aldrich a renowned pharmaceutical firm in Israel.

With the signing of this Letter of Intent with the Israelis, Neuro-Biotech gains a strong foothold and is able to pursue in an accelerated way the implementation of its Licensee network throughout the world. This allows the Company to initiate the next phase of its development plan namely the creation of its own "Technological Showcase" to support the training of technicians and the development of new products.

For more information on Neuro-Biotech Corp or to contact a company representative, please visit: www.neuro-biotechcorp.com

FORWARD LOOKING STATEMENTS
This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

CONTACT
Neuro-Biotech Corp.
Dr. Claude Poulin
41 61 500 05 16
info@neuro-agora.com
www.neuro-biotechcorp.com

SOURCE Neuro-Biotech Corp.

For further information:

Neuro-Biotech Corp.
Dr. Claude Poulin
41 61 500 05 16
info@neuro-agora.com
www.neuro-biotechcorp.com

Profil de l'entreprise

Neuro-Biotech Corp.

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.